Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS
- Status
- COMPLETED
- Phase
- NA
Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- N/A
HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- NA
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- N/A
EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2
- Status
- WITHDRAWN
- Phase
- PHASE1
Biological Predictive Factors of Response to ESA in Low Risk MDS Patients
- Status
- COMPLETED
- Phase
- PHASE4
COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1